Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Employment agrmnt Director departure Quarterly results
|
TG THERAPEUTICS, INC. (TGTX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/09/2023 |
SC 13G/A
| FMR LLC reports a 4.9% stake in TG THERAPEUTICS INC |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.7% stake in TG Therapeutics Inc. |
02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
10/11/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.2% stake in TG Therapeutics Inc. |
07/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/01/2022 |
SC 13G/A
| BlackRock Inc. reports a 6.2% stake in TG THERAPEUTICS, INC. |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
06/10/2020 |
SC 13G/A
| RA CAPITAL MANAGEMENT, LLC reports a 10.8% stake in TG THERAPEUTICS, INC. |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| venBio Select Advisor LLC reports a 1% stake in TG Therapeutics, Inc. |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/24/2020 |
SC 13G/A
| INTEGRATED CORE STRATEGIES LLC reports a 3.4% stake in TG THERAPEUTICS, INC. |
06/07/2019 |
SC 13G/A
| BlackRock Inc. reports a 4.9% stake in TG THERAPEUTICS, INC. |
02/14/2019 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 4.6% stake in TG Therapeutics, Inc. |
02/13/2019 |
SC 13G/A
| FMR LLC reports a 3.3% stake in TG THERAPEUTICS INC |
02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2018 |
SC 13G/A
| FMR LLC reports a 7% stake in TG THERAPEUTICS INC |
04/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
03/11/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/03/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
02/13/2008 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 5.9% stake in Manhattan Pharmaceuticals, Inc. |
02/13/2007 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 6.6% stake in Manhattan Pharmaceuticals, Inc. |
02/05/2007 |
SC 13G/A
| GIMBERT JOAN PONS reports a 6.8% stake in Manhattan Pharmaceuticals, Inc. |
02/14/2006 |
SC 13G/A
| BALYASNY ASSET MANAGEMENT LLC reports a 3.2% stake in MANHATTAN PHARMACEUTICALS, INC. |
|
|
|